Latest Guard Therapeutics News & Updates

See the latest news and media coverage for Guard Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Guard Therapeutics

Drug formulation platform developer

guardtherapeutics.com
Headquarters
Stockholm, Sweden
Company type
Public company
Number of employees
2–10
Industry
Pharmaceuticals

Last updated

Latest news about Guard Therapeutics

In short: Guard Therapeutics completed a reverse takeover of Disruptive Pharma and executed an in-kind share issue to maintain its Nasdaq listing.

Company announcements

Guard Therapeutics

Guard Therapeutics announces Nasdaq observation status

Nasdaq notes insufficient active operations, risking delisting by June 17, 2026. Company evaluates merger or reverse acquisition; may recommend delisting and liquidation if no deal.

Unlock all announcements with a

Media coverage

Dagens industri

Guard Therapeutics gets to stay on NGM

The biotech company Guard Therapeutics has received conditional approval from Nasdaq Stockholm for continued listing of the company's shares on Nasdaq First North Growth Market, within the framework of the planned reverse acquisition of Disruptive Pharma.

The Wall Street Journal

Guard Therapeutics International AB

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least...

Dagens industri

Reduced losses for Guard Therapeutics

Guard Therapeutics reports a result of minus 6.4 million kronor (minus 34.2) for the first quarter of 2026. Liquid funds at the end of...

Unlock all articles with a

Never miss news about Guard Therapeutics

Track Guard Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.